U.S. Customs and Border Protection has announced that as of May 2 it will end its test of the electronic transmission through the Automated Commercial Environment of data elements required by the Food and Drug Administration’s admissibility process for imports of FDA-regulated commodities. CBP states that ACE is now capable of accepting electronic entries for such goods via the FDA PGA message set and that all importers of such goods should now use ACE for their electronic filings.

CBP is not yet decommissioning the Automated Commercial System for transmitting FDA data but states that in the near future ACE will be the sole authorized electronic data interchange system for these filings.

Copyright © 2021 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.